These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 21272804)

  • 21. [Nodular regenerative hyperplasia of the liver associated with azathioprine therapy].
    Duvoux C; Kracht M; Lang P; Vernant JP; Zafrani ES; Dhumeaux D
    Gastroenterol Clin Biol; 1991; 15(12):968-73. PubMed ID: 1783253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Azathioprine pancreatitis in inflammatory bowel disease and successful subsequent treatment with mercaptopurine.
    Alexander S; Dowling D
    Intern Med J; 2005 Sep; 35(9):570-1. PubMed ID: 16105163
    [No Abstract]   [Full Text] [Related]  

  • 23. Portal hypertension in the presence of minimal liver damage in Crohn's disease on long-term azathioprine: possible endothelial cell injury.
    Arnott ID; Ghosh S
    Eur J Gastroenterol Hepatol; 2000 May; 12(5):569-73. PubMed ID: 10833103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thiopurine-induced pancreatitis in inflammatory bowel diseases.
    Ledder O; Lemberg DA; Day AS
    Expert Rev Gastroenterol Hepatol; 2015 Apr; 9(4):399-403. PubMed ID: 25494551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Idiopathic portal hypertension regarding thiopurine treatment in patients with inflammatory bowel disease.
    Suárez Ferrer C; Llop Herrera E; Calvo Moya M; Vera Mendoza MI; González Partida I; González Lama Y; Matallana Royo V; Calleja Panero JL; Abreu García L
    Rev Esp Enferm Dig; 2016 Feb; 108(2):79-83. PubMed ID: 26838489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thiopurine therapy in inflammatory bowel disease.
    Ha C; Dassopoulos T
    Expert Rev Gastroenterol Hepatol; 2010 Oct; 4(5):575-88. PubMed ID: 20932143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine.
    Roblin X; Serre-Debeauvais F; Phelip JM; Faucheron JL; Hardy G; Chartier A; Helluwaert F; Bessard G; Bonaz B
    Aliment Pharmacol Ther; 2005 Apr; 21(7):829-39. PubMed ID: 15801918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mercaptopurine and inflammatory bowel disease: the other thiopurine.
    Bermejo San José F; Algaba A; López Durán S; Guerra I; Aicart M; Hernández-Tejero M; Garrido E; de Lucas M; Bonillo D; López Sanromán A
    Rev Esp Enferm Dig; 2017 Jan; 109(1):10-16. PubMed ID: 27809554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of lymphoma in patients with ulcerative colitis treated with thiopurines: a nationwide retrospective cohort study.
    Khan N; Abbas AM; Lichtenstein GR; Loftus EV; Bazzano LA
    Gastroenterology; 2013 Nov; 145(5):1007-1015.e3. PubMed ID: 23891975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients.
    Wong DR; Pierik M; Seinen ML; van Bodegraven AA; Gilissen LP; Bus P; Bakker JA; Masclee AA; Neef C; Engels LG; Hooymans PM
    J Crohns Colitis; 2014 Feb; 8(2):120-8. PubMed ID: 23932783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tolerability and safety of mercaptopurine in azathioprine-intolerant patients with inflammatory bowel disease.
    Lees CW; Maan AK; Hansoti B; Satsangi J; Arnott ID
    Aliment Pharmacol Ther; 2008 Feb; 27(3):220-7. PubMed ID: 17988235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severe life-threatening diarrhea caused by azathioprine but not by 6-mercaptopurine.
    Marbet U; Schmid I
    Digestion; 2001; 63(2):139-42. PubMed ID: 11244253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thiopurines in inflammatory bowel disease: pharmacogenetics, therapeutic drug monitoring and clinical recommendations.
    Al Hadithy AF; de Boer NK; Derijks LJ; Escher JC; Mulder CJ; Brouwers JR
    Dig Liver Dis; 2005 Apr; 37(4):282-97. PubMed ID: 15788214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myelotoxicity and hepatotoxicity during azathioprine therapy.
    de Boer NK; Mulder CJ; van Bodegraven AA
    Neth J Med; 2005 Dec; 63(11):444-6. PubMed ID: 16397313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent advances using immunomodulators for inflammatory bowel disease.
    Nielsen OH; Bjerrum JT; Herfarth H; Rogler G
    J Clin Pharmacol; 2013 Jun; 53(6):575-88. PubMed ID: 23408468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine.
    Vernier-Massouille G; Cosnes J; Lemann M; Marteau P; Reinisch W; Laharie D; Cadiot G; Bouhnik Y; De Vos M; Boureille A; Duclos B; Seksik P; Mary JY; Colombel JF
    Gut; 2007 Oct; 56(10):1404-9. PubMed ID: 17504943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How thiopurines are used for the treatment of inflammatory bowel diseases: an Italian survey.
    Saibeni S; Kohn A; Meucci G; Papi C;
    Dig Liver Dis; 2015 Feb; 47(2):170-3. PubMed ID: 25467827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cholestatic hepatocellular injury with azathioprine: a case report and review of the mechanisms of hepatotoxicity.
    Romagnuolo J; Sadowski DC; Lalor E; Jewell L; Thomson AB
    Can J Gastroenterol; 1998 Oct; 12(7):479-83. PubMed ID: 9812167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety of thiopurine therapy in inflammatory bowel disease: long-term follow-up study of 3931 patients.
    Chaparro M; Ordás I; Cabré E; Garcia-Sanchez V; Bastida G; Peñalva M; Gomollón F; García-Planella E; Merino O; Gutiérrez A; Esteve M; Márquez L; Garcia-Sepulcre M; Hinojosa J; Vera I; Muñoz F; Mendoza JL; Cabriada JL; Montoro MA; Barreiro-de Acosta M; Ceña G; Saro C; Aldeguer X; Barrio J; Maté J; Gisbert JP
    Inflamm Bowel Dis; 2013 Jun; 19(7):1404-10. PubMed ID: 23665964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.